Animal Stem Cell Therapy Market By Product Type (Autologous Stem Cell Therapy and Allogeneic Stem Cell Therapy), By Type of Stem Cells (Mesenchymal Stem Cells, Hematopoietic Stem Cells, Neural Stem Cells, and Induced Pluripotent Stem Cells), By Application (Osteoarthritis, Skin regeneration, Neurodegenerative diseases, and Autoimmune diseases), Species (Dogs, Cats and Horses), and End-User (Veterinary Clinics, Research Laboratories and Universities and Academic Institutions ), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Product Type

• Autologous Stem Cell Therapy
• Allogeneic Stem Cell Therapy

By Type of Stem Cells

• Mesenchymal Stem Cells
• Hematopoietic Stem Cells
• Neural Stem Cells
• Induced Pluripotent Stem Cells

By Application

• Osteoarthritis
• Skin regeneration
• Autoimmune diseases
• Neurodegenerative diseases

Species  

• Dogs
• Cats
• Horses

End-User

• Veterinary Clinics
• Research Laboratories
• Universities and Academic Institutions

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• VetStem Biopharma
• U.S. Stem Cell, Inc.
• Medivet Biologics LLC
• Cell Therapy Sciences
• VetCell Therapeutics
• Celavet Inc.
• Animal Cell Therapies, Inc.
• Kintaro Cells Power
• J-ARM
• Magellan Stem Cells
• Animal Stem Care
• StemBioSys Inc.
• Pluristem Therapeutics
• ZyGEM Corporation
• Vetsource